InvestorsHub Logo
Followers 11
Posts 292
Boards Moderated 0
Alias Born 03/11/2011

Re: jbem777 post# 33411

Tuesday, 10/13/2015 9:30:07 AM

Tuesday, October 13, 2015 9:30:07 AM

Post# of 48316
Thank you Jbem for the response, your straight forwardness is appreciated. I agree about not shorting, because it just doesn’t feel as good and it does not help to develop some of that critical thinking that you are referring to. Even though the tactic is needed for the market, it is not productive for the economy. I also agree about Punit Dhillon’s past mistakes due to his lack of experience and how it has affected the company. If Dr. Pierce would have begun with the company from day one, a lot of wasted time and money could have been avoided. By the same token, that lack of experience is what attracted Dhillon to Dr. Pierce and recently to Dr. Meininger, which in turn has attracted me to the science of the company. I am a true believer of evolving technology, and the opening of cells to penetrate a smaller amount of a toxic drug in order to achieve greater results just makes a lot of sense. But like you have said, only time will tell if Oncosec is worth the investment. In the meantime, I also appreciate the information you have provided me from other opportunities.

Good trading to you as well.